With 350+ participants representing the core of China’s market, the Biopharma Development & Production Week is back to spur industry learning, showcase innovation and enable business contacts. With 3 co located conferences, 70+ speakers and over 60 technical and commercial sessions, this is without doubt the only forum with demonstrated value add for participants.
Against the bedrock of emerging and disruptive technologies, new generation facilities and continuous process improvement, participants will get quality practical information that enables them to develop advance capabilities in developing and manufacturing cell lines, biosimilars, biobetters, antibodies, vaccines and novel biologics.
Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.
Vice President, Manufacturing , Innovent Biologics
Managing Partner, Quadria Capital Investment Management Pte Ltd, Singapore
CIO, livzon Pharmaceutical Group
Chief Operating Officer, Valitacell, Ireland
Head of Global Distribution, Solentim
Dr Zhang Peiqing
Analytical Science and Technology Coordinator, Novartis
Zhaohui Sunny Zhou
Professor, Department of Chemistry and Chemical Biology Faculty Fellow, Barnett Institute of Chemical and Biological Analysis Northeastern University, Boston, Massachusetts
Dr. John Yan
Applications Scientist, ProZyme
Hung Fai Poon
Chief Scientific Officer, Zhejiang Hisun Pharmaceutical Co., Ltd, China
Prof. David James
University of Sheffield
Ng Say Kong
Staff Scientist, Animal Cell Technology 2, Bioprocessing Technology Institute, A*STAR
Vice-President, Shenogen Pharma Group, China
Vice President, Zhejiang Doer Biologics Co.
VP & Site Head of Manufacturing, Wuxi AppTec
Dr. Jinyou Zhang
Senior Vice President/Head, Bio development and manufacturing, BeiGene Beijing Co Ltd
Barbara A. Paldus, Ph.D.
Vice President & General Manager, Finesse, part of Thermo Fisher Scientific
President & CEO, Kunshan Zotek Kinglai Co. Ltd. U.K.
Managing Director of Microbial Solutions, Greater China Region, Charles River Laboratories
Dr Yvan Ruland
Technology Manager Biopharma, Novasep
M.Sc. Vice President Head of CMC General Manager, Generon Beijing
Former Director, Quality Assurance, Amgen Singapore
Head of QC Laboratory 2 & Head of Microbial Control Team, WuXi Biologics
Dr. Dennis Yu Xia
Vice President of Manufacturing and Quality, Akeso Bio
Dr. John Zeng
Executive Vice President, Bioprocess Development & Pilot Plant Manufacturing, Shanghai Zerun Biotech Co Ltd
Head of Bioprocess, ZaiLab, Ltd.
Business Development Manager, Pall Life Sciences
Dr. Christopher J. Hickey
Senior Director Government Affairs, Market Access & Communications, Pfizer
Dr. Scott Liu
President and CEO, Shanghai Henlius Biotech Inc.
Dr. Lutz Hilbrich
Head Strategic Task Force Biologics, Sanofi
Assistant Director, WuXi Biologics
Vice Director, Drug Research Institutes, Biopharmaceutical Institute, Jiangsu Aosaikang Pharmaceutical Co Ltd, China
Dr. Jacqueline Ming Liu
Vice President, TOT Biopharma, Taiwan
Dr Qiwei Wu
Ph.D, Vice President of Process Development and Manufacturing, Livzon Mabpharma
Dr Amy Hong Que
Vice President - Quality, Innovent Biologics
Chief Medical Officer, Shanghai Fosun Pharma
Prof. Dr. Florian Turk
Head Global Payor Marketing, Sales and Relations, Sandoz Biopharmaceuticals Sandoz International GmbH, Germany
Associate Vice President, Division of Project Development, Mycenax Biotech Inc., Taiwan
Vice President of Business Development, Samsung Bioepis, Korea
Dr. Xin Zhang
Head of Global Clinical Operations and Affairs, Shanghai Henlius Biotech Co Ltd, China
Director, Product Development, Zumutor Biologics, India
Team Leader of R&D CMC/PM, Celltrion R&D, Korea
General Manager - Business Development & Licensing, Intas Pharmaceuticals, India
Senior Vice President and Chief Medical Officer - Global Clinical Operations and Affairs, Shanghai Henlius Biotech Co Ltd, China
Still have a question?